VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,635,000 | -25.6% | 50,000 | -50.0% | 2.12% | -33.7% |
Q1 2018 | $2,198,000 | -62.2% | 100,000 | -54.5% | 3.20% | -52.3% |
Q3 2016 | $5,815,000 | +19.9% | 220,000 | +25.7% | 6.72% | +41.6% |
Q2 2016 | $4,849,000 | – | 175,000 | – | 4.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |